| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,475 |
4,789 |
$1.91M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,336 |
4,738 |
$662K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,842 |
2,194 |
$649K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,127 |
1,025 |
$630K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,741 |
1,599 |
$412K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,045 |
5,368 |
$146K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,789 |
3,546 |
$89K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,143 |
913 |
$71K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,046 |
832 |
$66K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,562 |
2,374 |
$42K |
| 93356 |
|
1,437 |
1,176 |
$37K |
| 71046 |
Radiologic examination, chest; 2 views |
962 |
868 |
$25K |
| 81025 |
|
2,019 |
1,862 |
$14K |
| 93246 |
|
862 |
721 |
$14K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
175 |
156 |
$12K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
310 |
267 |
$12K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
173 |
148 |
$11K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
13 |
12 |
$11K |
| 87634 |
|
423 |
379 |
$10K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
12 |
12 |
$9K |
| 92552 |
|
160 |
155 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,033 |
873 |
$8K |
| 81003 |
|
4,275 |
3,729 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
93 |
89 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
85 |
66 |
$5K |
| 51798 |
|
220 |
190 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
526 |
501 |
$5K |
| 93296 |
|
260 |
243 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
270 |
236 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
526 |
382 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
33 |
32 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
164 |
142 |
$3K |
| 81002 |
|
1,411 |
1,173 |
$2K |
| 93017 |
|
14 |
14 |
$2K |
| 73630 |
|
62 |
53 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
527 |
445 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
1,238 |
1,006 |
$1K |
| 73562 |
|
30 |
26 |
$1K |
| 95886 |
|
38 |
37 |
$929.85 |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
63 |
53 |
$923.46 |
| 84443 |
Thyroid stimulating hormone (TSH) |
20 |
17 |
$889.66 |
| 73610 |
|
13 |
12 |
$860.17 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,880 |
1,518 |
$835.00 |
| 80305 |
|
119 |
97 |
$738.90 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
64 |
63 |
$613.28 |
| 82962 |
|
205 |
176 |
$424.35 |
| 80053 |
Comprehensive metabolic panel |
122 |
116 |
$411.92 |
| 73130 |
|
30 |
26 |
$410.77 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
48 |
46 |
$316.78 |
| 94010 |
|
17 |
17 |
$296.14 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
637 |
577 |
$204.25 |
| 80061 |
Lipid panel |
19 |
17 |
$195.92 |
| 81001 |
|
696 |
605 |
$177.50 |
| 86580 |
|
25 |
12 |
$175.29 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
48 |
38 |
$110.20 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
388 |
297 |
$74.58 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
48 |
40 |
$46.05 |
| 85027 |
|
922 |
778 |
$28.20 |
| 71045 |
Radiologic examination, chest; single view |
32 |
27 |
$17.41 |
| 84075 |
|
231 |
196 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
58 |
41 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
64 |
45 |
$0.00 |
| 82040 |
|
231 |
196 |
$0.00 |
| 93320 |
|
12 |
12 |
$0.00 |
| 87077 |
|
13 |
13 |
$0.00 |
| 84484 |
|
16 |
12 |
$0.00 |
| 74022 |
|
13 |
12 |
$0.00 |
| 96161 |
|
26 |
24 |
$0.00 |
| 85007 |
|
526 |
430 |
$0.00 |
| 96160 |
|
238 |
209 |
$0.00 |
| 84460 |
|
231 |
196 |
$0.00 |
| 84450 |
|
232 |
197 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
305 |
273 |
$0.00 |
| 82247 |
|
231 |
196 |
$0.00 |
| 84155 |
|
231 |
196 |
$0.00 |
| 93325 |
|
149 |
146 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
45 |
38 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
20 |
16 |
$0.00 |